Central line infections in ICU patients
Part of Blood & lymphatic, Infections clinical trials.
This study is looking at infections from central lines (special IVs in large veins) in ICU patients across China. It aims to understand how common these infections are and what factors contribute to them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be in the ICU with a central line (a special IV in a large vein) that will stay in for at least 48 hours.
- Your central line should have been placed either in the ICU or within the last 24 hours before you arrived.
- If you have been readmitted to the ICU during this stay, you cannot take part.
- You cannot be pregnant or breastfeeding.
- You must be willing to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method to prevent infections from central lines (special IVs placed in large veins) in intensive care units. If you have a central line in place for more than 24 hours, this research may help improve your safety by finding better ways to avoid catheter-related bloodstream infections.
This study is about finding how common bloodstream infections are in people with central lines (a special IV for long-term medicines). It will help doctors learn how to prevent these infections.
This study aims to reduce infections that can happen when you have a central line, a special tube placed in a large vein to give medicines or fluids. Participating may help improve safety for patients like you.
This study looks at whether removing a central line (a tube in a large vein) in the ICU increases the risk of blood clots. It may help doctors understand how to prevent clots in ICU patients.
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
This study tests a new approach to prevent infections on central venous catheters (thin tubes inserted into large veins) in hospital intensive care units. Researchers will study catheters that already show signs of bacterial growth to understand how to better protect patients from catheter-related infections.
Hear when a new CLABSI - Central Line Associated Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.